135 related articles for article (PubMed ID: 6440414)
21. Significance of immunologic factors in cystic fibrosis.
Przyklenk B; Bauernfeind A
Scand J Gastroenterol Suppl; 1988; 143():103-9. PubMed ID: 2455329
[TBL] [Abstract][Full Text] [Related]
22. Exploring the expression of Pseudomonas aeruginosa genes directly from sputa of cystic fibrosis patients.
Barthe C; Nandakumar S; Derlich L; Macey J; Bui S; Fayon M; Crouzet M; Garbay B; Vilain S; Costaglioli P
Lett Appl Microbiol; 2015 Nov; 61(5):423-8. PubMed ID: 26174137
[TBL] [Abstract][Full Text] [Related]
23. Antibodies against chromosomal beta-lactamase.
Giwercman B; Rasmussen JW; Cioufu O; Clemmentsen I; Schumacher H; Høiby N
Antimicrob Agents Chemother; 1994 Oct; 38(10):2306-10. PubMed ID: 7840561
[TBL] [Abstract][Full Text] [Related]
24. Host inflammatory responses to first isolation of Pseudomonas aeruginosa from sputum in cystic fibrosis.
Elborn JS; Cordon SM; Shale DJ
Pediatr Pulmonol; 1993 May; 15(5):287-91. PubMed ID: 8327287
[TBL] [Abstract][Full Text] [Related]
25. Pseudomonas aeruginosa infection in cystic fibrosis. Relationship between mucoid strains of Pseudomonas aeruginosa and the humoral immune response.
Hoiby N
Acta Pathol Microbiol Scand B Microbiol Immunol; 1974 Aug; 82(4):551-8. PubMed ID: 4213330
[No Abstract] [Full Text] [Related]
26. Analysis of IgA antibody to Pseudomonas aeruginosa in sera and sputa of patients with chronic airway diseases.
Noda Y; Yasuoka S; Inoue I; Tani K; Fujisawa K; Ogura T
Intern Med; 1992 May; 31(5):575-82. PubMed ID: 1504417
[TBL] [Abstract][Full Text] [Related]
27. Combined evaluation of circulating immune complexes and antibodies to Pseudomonas aeruginosa as an immunologic profile in relation to pulmonary function in cystic fibrosis.
Dasgupta MK; Zuberbuhler P; Abbi A; Harley FL; Brown NE; Lam K; Dossetor JB; Costerton JW
J Clin Immunol; 1987 Jan; 7(1):51-8. PubMed ID: 3104391
[TBL] [Abstract][Full Text] [Related]
28. [Production of elastase, exotoxin A and alkaline protease during bronchopulmonary exacerbations in patients with mucoviscidosis chronically infected by Pseudomonas aeruginosa].
Jaffar-Bandjee MC; Carrere J; Bally M; Chazalette JP; Galabert C
Pathol Biol (Paris); 1994 May; 42(5):505-9. PubMed ID: 7824322
[TBL] [Abstract][Full Text] [Related]
29. Circulating soluble immune complexes containing pseudomonas antigens in cystic fibrosis.
Pitcher-Wilmott RW; Levinsky RJ; Matthew DJ
Arch Dis Child; 1982 Aug; 57(8):577-81. PubMed ID: 6810763
[TBL] [Abstract][Full Text] [Related]
30. Circulating immune complexes, antibodies to Pseudomonas aeruginosa, and pulmonary status in cystic fibrosis.
Lagacé J; Mercier J; Fréchette M; Fournier D; Dubreuil M; Lamarre A; Lapointe JR; Montplaisir S
J Clin Lab Immunol; 1989 Sep; 30(1):7-11. PubMed ID: 2534928
[TBL] [Abstract][Full Text] [Related]
31. Inflammatory and immunological biomarkers are not related to survival in adults with Cystic Fibrosis.
Moffitt KL; Martin SL; Jones AM; Webb AK; Cardwell C; Tunney MM; Elborn JS
J Cyst Fibros; 2014 Jan; 13(1):63-8. PubMed ID: 23860440
[TBL] [Abstract][Full Text] [Related]
32. Pseudomonas aeruginosa and Burkholderia cenocepacia infections in patients affected by cystic fibrosis: serum resistance and antibody response.
Savoia D; Deplano C; Zucca M
Immunol Invest; 2008; 37(1):19-27. PubMed ID: 18214797
[TBL] [Abstract][Full Text] [Related]
33. Chronic Pseudomonas aeruginosa lung infection in cystic fibrosis. A longitudinal study of immune complex activity and inflammatory response in sputum sol-phase of cystic fibrosis patients with chronic Pseudomonas aeruginosa lung infections: influence of local steroid treatment.
Schiøtz PO; Jørgensen M; Flensborg EW; Faerø O; Husby S; Høiby N; Jacobsen SV; Nielsen H; Svehag SE
Acta Paediatr Scand; 1983 Mar; 72(2):283-7. PubMed ID: 6340415
[TBL] [Abstract][Full Text] [Related]
34. Proteolytic cleavage of the long pentraxin PTX3 in the airways of cystic fibrosis patients.
Hamon Y; Jaillon S; Person C; Giniès JL; Garo E; Bottazzi B; Ghamrawi S; Urban T; Subra JF; Bouchara JP; Mantovani A; Jeannin P; Delneste Y
Innate Immun; 2013 Dec; 19(6):611-22. PubMed ID: 23475792
[TBL] [Abstract][Full Text] [Related]
35. Comparison of the sensitivity of culture, PCR and quantitative real-time PCR for the detection of Pseudomonas aeruginosa in sputum of cystic fibrosis patients.
Deschaght P; De Baere T; Van Simaey L; Van Daele S; De Baets F; De Vos D; Pirnay JP; Vaneechoutte M
BMC Microbiol; 2009 Nov; 9():244. PubMed ID: 19943966
[TBL] [Abstract][Full Text] [Related]
36. Immunoglobulin allotypes and IgG subclass antibody response to Pseudomonas aeruginosa antigens in chronically infected cystic fibrosis patients.
Pressler T; Pandey JP; Espersen F; Pedersen SS; Fomsgaard A; Koch C; Høiby N
Clin Exp Immunol; 1992 Nov; 90(2):209-14. PubMed ID: 1424275
[TBL] [Abstract][Full Text] [Related]
37. Influence of DNA on the activities and inhibition of neutrophil serine proteases in cystic fibrosis sputum.
Dubois AV; Gauthier A; Bréa D; Varaigne F; Diot P; Gauthier F; Attucci S
Am J Respir Cell Mol Biol; 2012 Jul; 47(1):80-6. PubMed ID: 22343221
[TBL] [Abstract][Full Text] [Related]
38. IgA and IgG antibodies against surface antigens of Pseudomonas aeruginosa in sputum and serum from patients with cystic fibrosis.
Schiøtz PO; Høiby N; Permin H; Wiik A
Acta Pathol Microbiol Scand C; 1979 Jun; 87C(3):229-33. PubMed ID: 113981
[TBL] [Abstract][Full Text] [Related]
39. Association of systemic immune complexes, complement activation, and antibodies to Pseudomonas aeruginosa lipopolysaccharide and exotoxin A with mortality in cystic fibrosis.
Moss RB; Hsu YP; Lewiston NJ; Curd JG; Milgrom H; Hart S; Dyer B; Larrick JW
Am Rev Respir Dis; 1986 Apr; 133(4):648-52. PubMed ID: 3083745
[TBL] [Abstract][Full Text] [Related]
40. Isolation and characterization of circulating immune complexes in cystic fibrosis.
Moss RB; Hsu YP
Clin Exp Immunol; 1982 Feb; 47(2):301-8. PubMed ID: 6804143
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
